Skip to content

Respiratory Sarcopenia in Older Adults

Respiratory Sarcopenia in Older Adults: Prevalence, Associated Factors and Response to an Exercise Program

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06548984
Enrollment
50
Registered
2024-08-12
Start date
2024-09-01
Completion date
2025-12-31
Last updated
2024-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sarcopenia

Keywords

Sarcopsarcopenia, geriatrics, respiratory function

Brief summary

The objectives of this study are to describe the prevalence of respiratory sarcopenia, evaluate its pattern of evolution over a one-year follow-up, and determine the response to a therapeutic exercise program in older adults in a geriatric nursing clinic. A sample of approximately 115 older adults, of both sexes, from the geriatric nursing clinic of the Virgen de la Arrixaca Hospital, Murcia, will participate in the study. In the first stage, a prospective observational study will be carried out, with one year of follow-up, and subsequently a randomized controlled clinical trial, with patients who have been diagnosed with respiratory sarcopenia. In the clinical trial, patients will be divided into 3 groups: control, experimental 1 (diaphragmatic exercises) and experimental 2 (respiratory muscle training). Sociodemographic and clinical variables, physical function (palm grip, 5STS, 4MGS), respiratory function (respiratory muscle strength and diaphragmatic thickness) and health outcomes (respiratory infections, visit to the emergency department, hospitalization, falls, bedridden and/or death). Descriptive statistics, univariate and multivariate logistic regression models, Cox proportional hazards model and Kaplan-Meier curves will be used to analyze the data from the longitudinal study. To compare the differences between pre- and post-intervention of the clinical trial, a two-factor analysis of variance for repeated measures will be used. A P-value \<0.05 will be considered significant in all analyses. The recording and analysis of the data will be carried out with the IBM SPSS Statistics 24® program.

Interventions

Perform controlled and supervised diaphragmatic exercises

OTHERRespiratory muscle training

Perform respiratory muscle training with controlled and supervised devices

Sponsors

Felipe León Morillas
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* have functional ambulation (even with technical aids) * be able to obey simple commands, such as taking deep breaths * have sufficient oral occlusion capacity to perform respiratory tes

Exclusion criteria

* presence of acute respiratory diseases * serious orthopedic diseases that interfere with measurements * diagnosis of severe dementia * those who present any contraindication for performing respiratory pressure measurement tests, as established in the guidelines of the Spanish Society of Pulmonology and Thoracic Surgery (SEPAR).

Design outcomes

Primary

MeasureTime frameDescription
physical function hand grip24 MonthsHand grip: palm press strength
RESPIRATORY MUSCLE FUNCTION24 MonthsINSPIRATORY AND EXPIRATORY PRESSURE OF THE MUSCULATURE
ultrasound24 Monthsdiaphragm muscle thickness
body composition24 MonthsCalculation of bioimpedance
Physical function24 Monthsfive times sit-up test (5STS)
Physical function walking speed24 Monthswalking speed (4MGS)

Secondary

MeasureTime frameDescription
Sociodemografic24 monthssex, age, marital status and educational level

Countries

Spain

Contacts

Primary ContactSilvana L de Oliveira Sousa, Dr.
soliveira@um.es+34868884201
Backup ContactCarmelo S Gómez Martínez, Dr.
csgomez@ucam.edu

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026